Maintenance and repair agreement for ninds imagexpress micro confocal high-content imaging system (serial number 5150079)

Active Purchase Order Awarded Last action

Contract number
75N95025P00026
Awardee
Awarding agency
Obligated
$114,644

Award facts

Opportunity
Contract value 39% obligated
  • $114,644.00 Current, with exercised options
  • $294,438.00 Potential, with all options
Completion date 50% complete
  • Current, with exercised options
  • Potential, with all options
Funding agency
National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00001 $58,169
Original award $56,475

About this award

The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $294,438 firm fixed-price purchase order to Molecular Devices LLC on November 22, 2024, for maintenance and repair services on an ImageXpress Micro Confocal High-Content Imaging System located at the NIH Main Campus in Bethesda, Maryland. The contract extends through November 21, 2028, and encompasses preventive maintenance, repair services, parts replacement, software updates, and technical support provided by authorized technicians from the original equipment manufacturer. This non-competitive, brand-name award was issued without set-aside designations, reflecting Molecular Devices' status as the sole authorized provider of maintenance services for this proprietary imaging system.

Molecular Devices LLC, a San Jose, California-based subsidiary of Danaher Corporation, specializes in advanced bioanalytical measurement solutions and high-performance scientific instruments for life science research. The company is a frequent recipient of federal contracts across the National Institutes of Health and other agencies including the CDC, VA, FDA, and EPA. The service requirements include providing replacement parts within two business days and maintaining the imaging system in full operational condition to support NINDS's neurological research initiatives.

Quick answers

Who was awarded contract 75N95025P00026?

75N95025P00026 was awarded to Molecular Devices LLC by National Institute on Drug Abuse (National Institutes of Health) on November 22, 2024.

How much is contract 75N95025P00026 worth?

The government has obligated $114,644 on 75N95025P00026. Its potential value, with all options, is $294,438.

Which agency awarded contract 75N95025P00026?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95025P00026, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).

Was contract 75N95025P00026 competed?

The extent of competition for 75N95025P00026 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award